Tech Company Financing Transactions
EKR Therapeutics Funding Round
EKR Therapeutics, based in Bedminster, secured $13 million from Quaker Partners, Merrill Lynch Capital and NewSpring Capital.
Transaction Overview
Company Name
Announced On
8/15/2007
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Series C
Investors
Proceeds Purpose
The Company expects the new infusion of investment funds to facilitate continued favorable execution of its business strategy, thus, further fueling acceleration in EKR's long-term growth prospects.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
1545 US Highway 206
Bedminster, NJ 07921
USA
Bedminster, NJ 07921
USA
Phone
Website
Email Address
Overview
Headquartered in Bedminster, New Jersey, EKR Therapeutics is a specialty pharmaceutical company focused on the acute-care hospital setting. EKR is committed to serving the needs of this important segment of the healthcare market by providing novel products offering broader therapeutic potential and superior outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Bailye
Chief Operating Officer
Bill McKee
VP - Bus. Development
Bryan Stuart
VP - Operations
Susan Bacso
VP - Sales
Jon Zwinski
Browse more venture capital transactions:
Prev: 8/14/2007: DietTV.com venture capital transaction
Next: 8/15/2007: Sierra Surgical Technologies venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs